Mark Mossler - 14 Feb 2025 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Chief Accounting Officer
Signature
/s/ Shagha Russell, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
14 Feb 2025
Net transactions value
-$5,043
Form type
4
Filing time
18 Feb 2025, 16:55:06 UTC
Previous filing
10 Apr 2024
Next filing
18 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Tax liability $5,043 -1,586 -8% $3.18 18,204 14 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.